Kai-Ting WANG,Tsun-Yuan LIN,Mu-Kuei CHEN,Hsun-Jin JAN
申请号：
US16485604
公开号：
US20190365697A1
申请日:
2017.02.17
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides use of a composition comprising ferrous amino acid chelate for the manufacture of a medicament for treatment of liver dysfunction, wherein the medicament comprises an effective amount of the ferrous amino acid chelate composition and a pharmaceutically acceptable carrier. The present invention proves that the serum biochemistry values related to the liver function can be reduced by administering the composition comprising ferrous amino acid chelate. For animals whose liver functions cannot be improved by long-term administration of S-adenosylmethionine, their liver functions can be effectively improved by administration of the composition comprising ferrous amino acid chelate of the present invention instead. Furthermore, the composition comprising ferrous amino acid chelate can improve the functions of an aged liver.
